Metabolomic insights into pulmonary fibrosis: a mendelian randomization study

DOI: https://doi.org/10.1186/s12890-024-03079-6
IF: 3.1
2024-06-07
BMC Pulmonary Medicine
Abstract:This study leverages a two-sample Mendelian Randomization (MR) approach to explore the causal relationships between 1,400 metabolites and pulmonary fibrosis, using genetic variation as instrumental variables. By adhering to stringent criteria for instrumental variable selection, the research aims to uncover metabolic pathways that may influence the risk and progression of pulmonary fibrosis, providing insights into potential therapeutic targets.
respiratory system
What problem does this paper attempt to address?